𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease

✍ Scribed by Agarwal, Rajiv; Vasavada, Nina; Sachs, Nadine G.; Chase, Shawn

Book ID
109065494
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
172 KB
Volume
65
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FDA report: Ferumoxytol for intravenous
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Ferahemeβ„’ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise